Biden Restores Health Care Protection for Gay and Transgender Americans
Policy will bring HHS into line with Supreme Court decision that said sex discrimination laws in workplaces also protect gay and transgender people (Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - May 12, 2021 Category: Psychiatry Tags: Cardiology, Dermatology, Endocrinology, Family Medicine, Geriatrics, Gastroenterology, Gynecology, Infections, AIDS, Internal Medicine, Allergy, Critical Care, Emergency Medicine, Nephrology, Neurology, Nursing, Oncology, Ophthalmology, Orthopedics, ENT, Source Type: news

Primary Breast Tumors Often Switch HER2 Status on Relapse Primary Breast Tumors Often Switch HER2 Status on Relapse
A substantial proportion of primary breast tumors switch from HER2-0 to HER2-low expression upon relapse, possibly widening the opportunity to treat patients with novel agents.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 11, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

O'Neal Comprehensive Cancer Center selected for racial bias pilot program
The O'Neal Cancer Center has been selected for a pilot program addressing racial inequality in cancer care. (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - May 11, 2021 Category: Pharmaceuticals Authors: Tyler Patchen Source Type: news

Whiterabbit emerges from stealth with FDA clearance for AI breast cancer screening tool
The company has developed a line of products targeting the mammography space to enable early and accurate breast cancer detection.     (Source: mobihealthnews)
Source: mobihealthnews - May 11, 2021 Category: Information Technology Source Type: news

Hoefer Welker designs Kansas' first facility for alternative cancer treatment
Hoefer Welker designed the new treatment facility within the University of Kansas Health System, one of only 38 proton therapy centers in the U.S. It's scheduled to open in January. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 11, 2021 Category: American Health Authors: Mary King Source Type: news

UAMS Researcher Gets $1.27M for Cancer Study
A researcher with the Winthrop P. Rockefeller Cancer Institute gets a five-year, $1.27 million grant to work toward developing two treatment options for acute myeloid leukemia patients. (Source: Arkansas Business - Health Care)
Source: Arkansas Business - Health Care - May 11, 2021 Category: American Health Source Type: news

FDA Grants Bold Therapeutics' BOLD-100 an Orphan Drug Designation (ODD) in the Treatment of Gastric Cancer
VANCOUVER, BC, May 11, 2021 -- (Healthcare Sales & Marketing Network) -- Bold Therapeutics, a clinical-stage biopharmaceutical company, is announcing that the U.S. Food & Drug Administration (FDA) has granted BOLD-100 an Orphan Drug Designation (ODD) in t... Biopharmaceuticals, Oncology, FDA Bold Therapeutics, BOLD-100, ruthenium, Gastric Cancer (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 11, 2021 Category: Pharmaceuticals Source Type: news

Schumer: 'The big lie is spreading like a cancer' among GOP
Senate Majority Leader Charles Schumer (D-N.Y.) offered fiery criticism of Republicans on Tuesday for efforts around the country to... (Source: Reuters: Health)
Source: Reuters: Health - May 11, 2021 Category: Consumer Health News Source Type: news

Latest Trends in the Management of Pulmonary Embolism Latest Trends in the Management of Pulmonary Embolism
Following clinical management of cancer-associated VTE in the hospital, direct oral anticoagulant therapy at discharge is your starting point, except in cases of intact luminal cancers.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - May 11, 2021 Category: Intensive Care Tags: Hospital Medicine News Source Type: news

Nuvalent Completes $135 Million Series B Financing to Advance Portfolio of Novel Precisely Targeted Kinase Inhibitors for Treatment-Resistant Cancers
Financing Led by Bain Capital Life Sciences - Andrew Hack, M.D., Ph.D., a Managing Director of Bain Capital Life Sciences, to Join Nuvalent Board of Directors Funding to Advance Parallel Lead Programs in ROS1-positive and ALK-positive NSCLC to Phase 1/2... Biopharmaceuticals, Oncology, Venture Capital Nuvalent, NSCLC (Source: HSMN NewsFeed)
Source: HSMN NewsFeed - May 11, 2021 Category: Pharmaceuticals Source Type: news

A Look at Three Decades of Real-World Mesothelioma Statistics
Despite clinical trials that often produce inflated expectations, real-world survival rates for pleural mesothelioma have failed to advance significantly over the past three decades, according to one recent study in Canada. Celebrated treatment advances have fallen short for the average patient diagnosed with this rare cancer caused by exposure to asbestos. “This is a story about a lack of progress. What we’ve seen is kind of underwhelming,” Dr. Paul Wheatley-Price, associate professor of medicine at University of Ottawa and thoracic oncologist at The Ottawa Hospital Cancer Centre, told The Mesothel...
Source: Asbestos and Mesothelioma News - May 11, 2021 Category: Environmental Health Authors: Fran Mannino Source Type: news

Gene-Targeted Drug Shows Promise Against a Form of Pancreatic Cancer
TUESDAY, May 11, 2021 -- There may be new hope for patients with a subset of pancreatic cancers tied to certain genetic mutations, a new study finds. The study involving 42 patients found that a " PARP inhibitor " drug called rucaparib (Rubraca), may... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 11, 2021 Category: General Medicine Source Type: news

Chlorophyll Water Is All Over TikTok. But Is It Actually Good For You?
Many claim the supplement can do everything from treat acne to prevent cancer. Here's what you should know. (Source: Science - The Huffington Post)
Source: Science - The Huffington Post - May 11, 2021 Category: Science Source Type: news

Woman who had breast implants removed urges Ottawa to mandate registry of medical devices
A British Columbia woman who learned second-hand that her breast implants had been linked to a rare form of cancer is demanding that the federal government mandate a system of personalized recall alerts for all items surgically implanted in people's bodies. (Source: CBC | Health)
Source: CBC | Health - May 11, 2021 Category: Consumer Health News Tags: News/Canada/British Columbia Source Type: news

Gene-Targeted Drug Shows Promise Against a Form of Pancreatic Cancer
Title: Gene-Targeted Drug Shows Promise Against a Form of Pancreatic CancerCategory: Health NewsCreated: 5/11/2021 12:00:00 AMLast Editorial Review: 5/11/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 11, 2021 Category: Cancer & Oncology Source Type: news

Obesity Raises Odds for Many Common Cancers
Title: Obesity Raises Odds for Many Common CancersCategory: Health NewsCreated: 5/10/2021 12:00:00 AMLast Editorial Review: 5/11/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 11, 2021 Category: Cancer & Oncology Source Type: news

New ultrasound technique detects fetal circulation problems
Researchers have developed a new ultrasound technique to monitor the placent...Read more on AuntMinnie.comRelated Reading: X-ray, CT reveal mummified ancient Egyptian was pregnant Fetal cardiovascular MRI helps diagnose congenital heart defects Lung ultrasound spots COVID-19 in newborns Pregnancy is safe for breast cancer survivors Imaging detects big, rare tumor protruding from fetus's mouth (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 11, 2021 Category: Radiology Source Type: news

Women with genetic disorder more reassured after breast screening
Women with a genetic disorder that increases their risk of breast cancer di...Read more on AuntMinnie.comRelated Reading: AI has opportunities for more acceptance in screening mammography USPSTF releases final research plan for breast cancer screening recs Mammography underutilized in Jamaica Is it time for population-based breast screening in India? AI can help classify masses found on breast ultrasound (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - May 11, 2021 Category: Radiology Source Type: news

Roche to present data from one of the most comprehensive oncology portfolios at the 2021 ASCO Annual Meeting showcasing advancements for people living with cancer
Basel, 11 May 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new data from clinical trials of 19 approved and investigational medicines across 20 cancer types will be presented at the 2021 ASCO Annual Meeting, which will be held 4-8 June, 2021. A total of 132 abstracts that include a Roche medicine will be presented at this year's meeting. These data advance oncology by showing the importance of making patient-centric treatment decisions and providing tailored medical care based on specific cancer types.“We will be presenting data from across our diverse oncology portfolio that has the potential to he...
Source: Roche Media News - May 11, 2021 Category: Pharmaceuticals Source Type: news

Roche to present data from one of the most comprehensive oncology portfolios at the 2021 ASCO Annual Meeting showcasing advancements for people living with cancer
Basel, 11 May 2021 - Roche (SIX: RO, ROG; OTCQX: RHHBY) today announced that new data from clinical trials of 19 approved and investigational medicines across 20 cancer types will be presented at the 2021 ASCO Annual Meeting, which will be held 4-8 June, 2021. A total of 132 abstracts that include a Roche medicine will be presented at this year's meeting. These data advance oncology by showing the importance of making patient-centric treatment decisions and providing tailored medical care based on specific cancer types.“We will be presenting data from across our diverse oncology portfolio that has the potential to he...
Source: Roche Investor Update - May 11, 2021 Category: Pharmaceuticals Source Type: news

Medicaid expansion alone does not resolve disparities in cancer care
(Brigham and Women's Hospital) A new analysis of National Cancer Database (NCDB) records conducted by researchers at Brigham and Women's Hospital indicates that while individuals experienced accelerated treatment timelines after the ACA, overall, hospitals that primarily serve minorities (MSHs) did not improve average delivery times for cancer treatments. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 11, 2021 Category: Cancer & Oncology Source Type: news

Tumor-promoting immune cells retrained to fight most aggressive type of brain cancer
(Massachusetts General Hospital) Using a targeted antibody calledαGITR, tumor-promoting immune cells called regulatory T cells (Tregs) can be reprogrammed into cancer-killing immune cells in glioblastomas. Combining theαGITR antibody with immune-checkpoint-blocking drugs may benefit patients with glioblastomas, the most aggressive and uniformly fatal type of brain tumor. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 11, 2021 Category: International Medicine & Public Health Source Type: news

Oregon State researchers discover new class of cancer fighting compounds
(Oregon State University) A team of Oregon State University scientists has discovered a new class of anti-cancer compounds that effectively kill liver and breast cancer cells. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - May 11, 2021 Category: International Medicine & Public Health Source Type: news

Lighting up biology from within
(University of Missouri-Columbia) A biochemical reaction between an enzyme called luciferase and oxygen causes fireflies to glow and is considered one of the most well-known examples of bioluminescence in nature. Now, an international team of researchers led by Elena Goun at the University of Missouri is working to harness the power of bioluminescence in a low-cost, noninvasive portable medical imaging device that could one day be applied to many uses in biomedical research, translational medicine and clinical diagnoses. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 11, 2021 Category: Cancer & Oncology Source Type: news

Heligenics AND The Jackson Laboratory announce new collaboration on ERBB2 breast cancer gene
(Jackson Laboratory) Heligenics, Inc. today announced a new collaboration with The Jackson Laboratory. This joint project will make available the functional output of Variants of Unknown Significance throughout key portion of the ERBB2 gene through the JAX Clinical Knowledgebase, a digital resource that connects clinicians and researchers around the globe in order to interpret complex cancer genomic profiles. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 11, 2021 Category: Cancer & Oncology Source Type: news

New research outlines a critical driver in an immune cell's defense against melanoma
(Huntsman Cancer Institute) Researchers at Huntsman Cancer Institute have found critical new insights into how cells defend against melanoma. In a report published in Nature Communications, the team describes how an enzyme called nicotinamide phosphoribosyltransferase, or NAMPT, initiates antitumor activity. The researchers suggest that new therapies strengthening this pathway in immune cells could be the foundation for more effective treatments against melanoma. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 11, 2021 Category: Cancer & Oncology Source Type: news

Low-dose, four-drug combo blocks cancer spread in mice
(eLife) Low doses of a four-drug combination helps prevent the spread of cancer in mice without triggering drug resistance or recurrence, shows a study published today in eLife. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 11, 2021 Category: Cancer & Oncology Source Type: news

Moffitt researchers discover regulatory pathway that blocks immune response against cancer
(H. Lee Moffitt Cancer Center& Research Institute) In a new article published in the journal Immunity, Moffitt Cancer Center researchers show that TIM-3 inhibits the STING signaling pathway in dendritic cells, thereby blocking their ability to elicit an immune response. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 11, 2021 Category: Cancer & Oncology Source Type: news

A personalized anti-cancer vaccine that works in mice
(University of Montreal Hospital Research Centre (CRCHUM)) Marie-Claude Bourgeois-Daigneault and her team at the CRCHUM are using mice to show how a combination of peptides and oncolytic viruses, used as an adjuvant, can provide effective immunization against cancer. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 11, 2021 Category: Cancer & Oncology Source Type: news

First-in-man clinical trial in S'pore for stem cell technology by SingHealth Duke-NUS AMC, Cordlife
(Duke-NUS Medical School) SingHealth Duke-NUS AMC and Cordlife partner to advance stem cell technology to first-in-man clinical trial in Singapore (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 11, 2021 Category: Cancer & Oncology Source Type: news

HKBU and Cornell University develop novel targeted therapy for breast cancer with nanotechnology and Chinese medicine
(Hong Kong Baptist University) Researchers from Hong Kong Baptist University (HKBU), in collaboration with Cornell University, have developed a novel targeted therapy for triple-negative breast cancer (TNBC) that uses a specially-designed nano-carrier to deliver the Chinese medicine compound gambogic acid (GA). The invention enhances the anti-cancer effect of GA and reduces its damage to off-target organs. The invention has the potential to become a more effective therapeutic option for TNBC. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 11, 2021 Category: Cancer & Oncology Source Type: news

Researchers identify genes responsible for loss of lung function
(Boston University School of Medicine) Researchers from Boston University School of Medicine (BUSM) have identified a panel of genes that are active in smokers and ex-smokers who experience faster loss of lung function over time. They believe these genes could be useful to predict which people are most at risk for smoking-related decline in lung function. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 11, 2021 Category: Cancer & Oncology Source Type: news

MD Anderson and Broad Institute launch new translational research platform focused on rare cancers
(University of Texas M. D. Anderson Cancer Center) MD Anderson and the Broad Institute have launched a translational research platform to study rare cancers. The initiative will lead to a first-of-its-kind resource for the scientific community and will help to accelerate new therapies for patients with rare tumor types. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - May 11, 2021 Category: Cancer & Oncology Source Type: news

Obesity Raises Odds for Many Common Cancers
(Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - May 11, 2021 Category: Cancer & Oncology Tags: Endocrinology, Gynecology, Oncology, Hepatology, Nutrition, News, Source Type: news

Why this life sciences leader is stepping away from the CEO seat — and what she plans to do next
The CEO was a cofounder of the diagnostics company 14 years ago, starting with a thyroid cancer test that has helped more than 100,000 patients avoid surgeries. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - May 10, 2021 Category: American Health Authors: Ron Leuty Source Type: news

Why this life sciences leader is stepping away from the CEO seat — and what she plans to do next
The CEO was a cofounder of the diagnostics company 14 years ago, starting with a thyroid cancer test that has helped more than 100,000 patients avoid surgeries. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - May 10, 2021 Category: Biotechnology Authors: Ron Leuty Source Type: news

Internal Medicine Residency, Fellowship Applications Up During Pandemic
Authors say increase may be due to lower barriers for virtual interviews (Source: Pulmonary Medicine News - Doctors Lounge)
Source: Pulmonary Medicine News - Doctors Lounge - May 10, 2021 Category: Respiratory Medicine Tags: Cardiology, Endocrinology, Gastroenterology, Infections, Internal Medicine, Allergy, Critical Care, Nephrology, Oncology, Pulmonology, Rheumatology, Geriatrics, Journal, Source Type: news

Obesity Raises Odds for Many Common Cancers
MONDAY, May 10, 2021 -- Being obese or overweight can increase the odds of developing several types of cancers, new research from the United Kingdom reveals. But shedding the excess pounds can lower the risk, researchers say. Reducing obesity cuts... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 10, 2021 Category: General Medicine Source Type: news

Freezing Tumors May Treat Low-Risk Breast Cancers
A first-of-its-kind study suggests that slow-growing breast cancers can be treated with a highly targeted tumor-freezing technique, eliminating the need for invasive surgery. (Source: WebMD Health)
Source: WebMD Health - May 10, 2021 Category: Consumer Health News Source Type: news

Possible Obesity Effect Detected in Cancer Death Rates Possible Obesity Effect Detected in Cancer Death Rates
The obesity epidemic in the United States may be slowing improvements in cancer mortality, according to a new study.Medscape Medical News (Source: Medscape Internal Medicine Headlines)
Source: Medscape Internal Medicine Headlines - May 10, 2021 Category: Internal Medicine Tags: Diabetes & Endocrinology News Source Type: news

Lockdown Loneliness Making Things Even Tougher for Cancer Patients
(Source: The Doctors Lounge - Psychiatry)
Source: The Doctors Lounge - Psychiatry - May 10, 2021 Category: Psychiatry Tags: Oncology, Psychiatry, Preventive Medicine, News, Source Type: news

Freezing Breast Cancer to Death Avoids Surgery Freezing Breast Cancer to Death Avoids Surgery
New results from a clinical trial of cryoablation for low-risk, early-stage breast cancer offer hope that the modality might one day be a treatment option in the US. But what's taking so long?Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 10, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

Deciding to Stop Cancer Treatment
For some people, cancer treatment stops working. When the risks and side effects outweigh the possible benefits, people may choose to stop cancer treatment. (Source: WebMD Health)
Source: WebMD Health - May 10, 2021 Category: Consumer Health News Source Type: news

Secondhand Smoke Exposure Tied to Oral Cancer Risk Secondhand Smoke Exposure Tied to Oral Cancer Risk
People who are exposed to secondhand smoke are more likely to develop oral cancers than their counterparts who don't have this exposure, a systematic review and meta-analysis suggests.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - May 10, 2021 Category: Consumer Health News Tags: Hematology-Oncology News Source Type: news

' Living at Work': Work-Life Balance in a Pandemic'Living at Work': Work-Life Balance in a Pandemic
A physician reaches out to colleagues for advice on rebalancing his professional and personal obligations.Medscape Oncology (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 10, 2021 Category: Consumer Health News Tags: Hematology-Oncology Commentary Source Type: news

BioNTech powers to profit on Covid vaccine demand
German group plans to invest proceeds in bid to become a leading force in cancer therapies (Source: FT.com - Drugs and Healthcare)
Source: FT.com - Drugs and Healthcare - May 10, 2021 Category: Pharmaceuticals Source Type: news

Better Survival After Lumpectomy Plus RT vs Mastectomy Better Survival After Lumpectomy Plus RT vs Mastectomy
Breast conservation surgery plus radiotherapy (RT) leads to better outcomes than mastectomy with or without RT for patients with early-stage disease.Medscape Medical News (Source: Medscape Hematology-Oncology Headlines)
Source: Medscape Hematology-Oncology Headlines - May 10, 2021 Category: Cancer & Oncology Tags: Hematology-Oncology News Source Type: news

Lockdown Loneliness Making Things Even Tougher for Cancer Patients
MONDAY, May 10, 2021 -- Fighting cancer can be a lonely battle, and new research shows that the coronavirus pandemic has made the experience even more isolating. Studies conducted before the pandemic found that 32% to 47% of cancer patients were... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - May 10, 2021 Category: General Medicine Source Type: news

' See Through the Symptoms' GP awareness campaign for never smoking lung cancers launched
Lung cancer in never-smokers is the UK's 8th most common cause of cancer-related death. The campaign alerts GPs to the symptoms of lung cancer, and signposts to a number of resources to aid early investigation and referral, which is key to improving outcomes. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - May 10, 2021 Category: Consumer Health News Source Type: news

Lockdown Loneliness Making Things Even Tougher for Cancer Patients
Title: Lockdown Loneliness Making Things Even Tougher for Cancer PatientsCategory: Health NewsCreated: 5/10/2021 12:00:00 AMLast Editorial Review: 5/10/2021 12:00:00 AM (Source: MedicineNet Cancer General)
Source: MedicineNet Cancer General - May 10, 2021 Category: Cancer & Oncology Source Type: news